Myrna Roach and Donald Jackson are the Penn Memory Center’s first two participants in the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s study (the “A4 study”), a historic prevention trial which is testing whether a new investigational treatment, called an amyloid antibody, can slow memory loss caused by Alzheimer’s disease.
“There’s a family history of Alzheimer’s disease,” says Ms. Roach, “so I’m interested in helping to find a cure for it, maybe in my lifetime.”
For more information about the A4 trial, click here.
